Murray Berkowitz
Neuromusculoskeletal Medicine & OMM · Alpharetta, GANPI 1306997861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,480 and has fallen 84.1% since, to $236 in 2023.
Across 115 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$307
- Bayer$290
- AbbVie$255
- Abbott$213
- Novo Nordisk$200
- Eisai Inc.$148
- plus $909 from 21 others
What the payments were for
- Food & beverage$2,314100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $307 |
| Bayer | 9 | $290 |
| AbbVie | 12 | $255 |
| Abbott | 14 | $213 |
| Novo Nordisk | 15 | $200 |
| Eisai Inc. | 4 | $148 |
| Corium, LLC | 5 | $120 |
| Amgen | 6 | $99 |
| Argenx US, Inc. | 3 | $78 |
| Bausch Health US, LLC | 3 | $72 |
| AstraZeneca | 5 | $71 |
| Jazz Pharmaceuticals Inc. | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Lundbeck LLC | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Dexcom, Inc. | 2 | $33 |
| IBSA Pharma Inc. | 2 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $24 |
| UCB, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromusculoskeletal medicine & omm providers in Georgiato place this figure against a meaningful peer group, so we don't.
Other neuromusculoskeletal medicine & omm in Alpharetta
- Thomas HolmesMarietta$108K
- Alan MaloonRoswell$74K
- Benjamin BarnesAugusta$50K
- Joseph HormesMarietta$6K
- Luckana ChayaMarietta$109
- Noel HoltzMarietta$63
- Elizabeth WilletsCumming$33
- Curtis SmithAugusta$16
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.